Prognostic factors for stage i ovarian carcinoma

International Journal of Gynecological Pathology

Volumn 29, Issue 1, 2010, Pages 1-7

  Seidman, Jeffrey D ^a   Yemelyanova, Anna V ^a,c   Khedmati, Fatemeh ^a   Bidus, Michael A ^b   Dainty, Louis ^b   Boice, Charles R ^a   Cosin, Jonathan A ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clear cell carcinoma; FIGO stage; Grade; Ovarian carcinoma; Prognosis; Serous carcinoma; Staging; Tumor rupture

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER MORTALITY; CANCER STAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 76149092195     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181af2372     Document Type: Article

References (39)

1. Seidman JD, Russell P, Kurman RJ. Surface epithelial tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2002:791-904.
2. Dembo AJ, Davy M, Stenwig AE, et al. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75:263-273
3. Ahmed FY, Wiltshaw E, A'Hern RP, et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 1996;14:2968-2975
4. Trimbos JB, Schueler JA, van der Burg M, et al. Watch and wait after careful surgical treatment and staging in welldifferentiated early ovarian cancer. Cancer 1991;67:597-602.
5. Elit L, Chambers A, Fyles A, et al. Systematic review of adjuvant care for women with stage I ovarian carcinoma. Cancer 2004;101:1926-1935
6. Gadducci A, Sartori E, Maggino T, et al. Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study. Int J Gynecol Cancer 1997;7:445-450
7. Bolis G, Colombo N, Pecorelli S, et al. Adjuvant treatment for early epithelial ovarian cancer: results of two randomized clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). Ann Oncology 1995;6:887-893
8. Piver MS, Malfetano J, Baker TR, et al. Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy. Gynecol Oncol 1992; 46:357-360
9. Sainz de la Cuesta R, Goff BA, Fuller AF Jr, et al. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms. Obstet Gynecol 1994;84:1-7.
10. Schueler JA, Cornelisse CJ, Hermans J, et al. Prognostic factors in well-differentiated early-stage epithelial ovarian cancer. Cancer 1993;71:787-795
11. Chan JK, Tian C, Monk B, et al. Prognostic factors for highrisk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer 2008;112:2202-2210
12. Leitao MM, Boyd J, Hummer A, et al. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am J Surg Pathol 2004;28:147-159
13. Bloss JD, Liao S-Y, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 1993;50:347-351
14. Seidman JD, Soslow RA, Vang R, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol 2004;35:918-933
15. Clement PB. Diseases of the peritoneum. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5th ed. New York: Springer-Verlag; 2002:729-789
16. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
17. Heintz APM, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynecol Obstet 2003;83(suppl 1):135-166
18. Ozols RF, Rubin SC, Thomas GM, et al. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecological Oncology. 3rd ed. New York: Lippincott, Williams & Wilkins; 2000:981-1058.
19. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 2004; 28:496-504.
20. Yemelyanova AV, Cosin JA, Bidus MA, et al. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer 2008;18: 465-469
21. Chan JK, Teoh D, Hu JM, et al. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008;109:370-376
22. Skirnisdottir I, Seidal T, Karlsson MG, et al. Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II. Int J Oncol 2005;26:177-183
23. Young RC, Brady MF, Nieberg RK, et al. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin-A Gynecologic Oncology Group study. J Clin Oncol 2003;21:4350-4355
24. Obermair A, Fuller A, Lopez-Varela E, et al. A new prognostic model for FIGO stage I epithelial ovarian cancer. Gynecol Oncol 2007;104:607-611 (Pubitemid 46251413)
25. Paramasivam S, Tripcony L, Crandon A, et al. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study. J Clin Oncol 2005; 23:5938-5942
26. Kommoss F, Kommoss S, Schmidt D, et al. Survival benefit for patients with advanced stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel. Gynecol Oncol 2005;97:195-199
27. Shimada M, Kigawa J, Kanamori Y, et al. Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging. Int J Gynecol Cancer 2005;15:601-605
28. Seidman JD, Horkayn-Szakaly I, Cosin JA, et al. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Gynecol Oncol 2006;103:703-708
29. Lachance JA, Shutter J, Atkins KA, et al. Utilization of a uniform grading system for interpreting serous ovarian cancer. Am J Obstet Gynecol 2008;199:189e1-6
30. Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol 2004;23:200-205
31. Kurman RJ, Shih I-M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008;27:151-160
32. Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001; 357:176-182
33. Mizuno M, Kikkawa F, Shibata K, et al. Long-term prognosis of stage I ovarian carcinoma. Oncology 2003;65:29-36.
34. Young RC, Decker DG, Wharton JT et al. Staging laparotomy in early ovarian cancer. JAMA 1983;250:3072-3076
35. Le T, Krepart GV, Lotocki RJ, et al. Clinically apparent early stage invasive ovarian epithelial carcinoma: should all be treated similarly? Gynecol Oncol 1999;74:252-254
36. ICON1 and EORTC-ACTION. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-112
37. Heintz APM, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. In: Pecorelli S, ed. 26th Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 2006;95:S161-92.
38. Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organization for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst 2003;95:113-125
39. International Collaborative Ovarian Neoplasm (ICON1) Collaborators. International collaborative ovarian neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer. J Natl Cancer Inst 2003;95:125-132